human
adenovirus
nonenvelop
doublestrand
dna
virus
exist
seven
speci
ag
greater
type
identifi
far
affect
differ
organ
caus
wide
spectrum
diseas
immunocompet
immunocompromis
individu
includ
pneumon
hepat
gastroenter
conjunct
although
adenovirus
import
respiratori
pathogen
haematolog
patient
adenoviru
surveil
blood
normal
perform
nontranspl
adult
patient
report
case
adenoviru
pneumon
led
fatal
dissemin
adenoviru
infect
adult
patient
chronic
lymphocyt
leukaemia
cll
chemotherapi
patient
old
man
cll
present
persist
cough
coryz
symptom
earli
past
medic
histori
epilepsi
rheumat
fever
never
smoke
cll
first
diagnos
late
leukaemia
progress
underw
six
cycl
chemotherapi
fcr
combin
fludarabin
cyclophosphamid
rituximab
next
month
complet
treatment
june
bone
marrow
clinic
find
show
complet
respons
treatment
chemoimmunotherapi
continu
acyclovir
mg
bd
cotrimoxazol
mg
bd
time
week
prophylaxi
still
take
time
present
respons
tcell
lymphopenia
persist
hospit
admiss
juli
helper
cell
l
april
present
histori
nonproduct
cough
rhinorrhoea
clinic
laboratori
featur
cll
time
serum
immunoglobulin
suppress
igg
gl
normal
rang
gl
tcell
low
l
normal
rang
l
although
transient
improv
product
cough
persist
despit
multipl
cours
antibiot
azithromycin
mg
od
coamoxiclav
mg
td
doxycyclin
mg
od
cours
oral
prednisolon
mg
od
ct
scan
sinus
show
right
maxillari
sinu
chang
consist
chronic
sinus
subsequ
refer
ear
nose
throat
specialist
manag
howev
radiolog
sinu
chang
felt
signific
specif
treatment
initi
patient
symptom
worsen
june
ct
scan
chest
show
centrilobular
nodular
chang
rightsid
patchi
consolid
surround
ground
glass
opac
halo
sign
rais
possibl
atyp
infect
includ
fungal
pathogen
patient
subsequ
prescrib
voriconazol
mg
bd
also
underw
bronchoscopi
later
month
bronchoalveolar
lavag
bal
sampl
cultur
haemophilu
influenza
neg
pathogen
includ
fungi
viral
screen
carri
sampl
respons
given
prolong
cours
coamoxiclav
mg
td
show
subsequ
clinic
improv
togeth
voriconazol
one
month
later
juli
howev
readmit
mark
deterior
product
cough
short
breath
exert
bilater
crepit
heard
examin
consist
chest
xray
show
bilater
patchi
consolid
creactiv
protein
mgl
start
intraven
iv
tazocin
g
td
clarithromycin
mg
bd
although
sign
improv
cours
week
symptom
persist
repeat
ct
scan
readmiss
show
ground
glass
chang
treeinbud
appear
nodular
chang
progress
previou
imag
underw
anoth
bronchoscopi
examin
start
treatment
dose
cotrimoxazol
mgkg
daili
divid
dose
caspofungin
mg
od
addit
serum
immunoglobulin
remain
low
sinc
chemotherapi
demonstr
panhypogammaglobulinaemia
intraven
immunoglobulin
ivig
gkg
administ
second
bal
posit
adenoviru
dna
pcr
test
use
inhous
respiratori
multiplex
pcr
screen
assay
describ
elsewher
betadglucan
test
bal
also
posit
pgml
neg
peripher
blood
fungal
bacteri
pneumocysti
tuberculosi
screen
neg
despit
left
midzon
consolid
persist
chest
imag
point
diagnos
adenoviru
pneumon
one
week
later
patient
remain
symptomat
persist
fever
peripher
blood
sent
adenoviru
pcr
result
million
copiesml
qualit
quantit
adenoviru
pcr
test
blood
sampl
perform
commerci
laboratori
micropatholog
ltd
coventri
uk
four
day
later
adenoviru
level
risen
million
copiesml
adenoviru
type
base
viral
sequenc
analysi
perform
micropatholog
ltd
coventri
uk
base
result
iv
cidofovir
mgkg
weekli
treatment
given
four
day
later
blood
adenoviru
dna
level
increas
million
copiesml
cours
follow
two
week
patient
deterior
term
respiratori
function
requir
transfer
intens
care
ventilatori
support
liver
function
also
deterior
time
bilirubin
alkalin
phosphatas
iul
despit
addit
measur
includ
dose
ivig
gkg
addit
ribavirin
iv
mgkg
die
result
dissemin
adenoviru
infect
multiorgan
failur
last
adenoviru
dna
level
three
day
death
million
copiesml
postmortem
investig
perform
thu
dissemin
adenoviru
infect
deem
caus
patient
multiorgan
failur
death
basi
high
level
viremia
coincid
patient
rapid
deterior
describ
case
sever
wellknown
risk
factor
sever
adenoviru
infect
includ
allogen
stem
cell
solidorgan
transplant
particularli
tcell
deplet
treatment
monoclon
antibodi
alemtuzumab
campath
antithymocyt
globulin
atg
sever
immunosuppress
use
treat
graftversushost
diseas
caus
sever
lymphopaenia
reduc
abil
host
cellmedi
immun
defend
adenoviru
infect
patient
chemotherapi
regimen
includ
fludarabin
sever
lymphopaenia
recognis
advers
effect
present
treatment
regimen
variou
viral
reactiv
occur
includ
hepat
b
bk
viru
herp
simplex
epsteinbarr
virus
cytomegaloviru
well
adenoviru
yet
case
note
throughout
period
acquir
infect
adenoviru
total
lymphocyt
count
remain
within
even
normal
rang
l
though
specif
function
test
although
fatal
adenoviru
infect
report
nontranspl
paediatr
adult
patient
chemotherapi
still
consensu
deal
isol
adenoviru
posit
result
peripher
nonblood
sampl
type
routin
basi
mani
patient
also
asymptomat
adenoviru
infect
virolog
viewpoint
sinc
system
antivir
drug
virostat
virucid
earlier
adenoviru
pcr
blood
test
allow
earlier
treatment
prevent
increas
viral
load
may
improv
clinic
outcom
howev
due
sever
nephrotox
natur
mainstay
treatment
intraven
cidofovir
transplant
team
reluct
prescrib
drug
empir
unless
definit
upward
trend
seen
adenoviru
blood
level
often
caus
delay
commenc
therapi
drug
dissemin
adenoviru
infect
thu
immunocompromis
patient
peripher
site
eg
nonblood
sampl
respiratori
stool
sampl
adenoviru
pcr
posit
result
would
recommend
serial
twice
weekli
monitor
adenoviru
pcr
test
perform
durat
specif
adv
ill
check
possibl
dissemin
adenoviru
infect
earlier
test
context
inexpens
would
allow
earlier
detect
dissemin
adenoviru
infect
turn
allow
treatment
commenc
earlier
could
signific
posit
clinic
impact
final
immunocompromis
patient
pathogen
bacteria
fungi
virus
screen
initi
investig
acut
infect
episod
allow
prompt
intervent
requir
